Septerna is a biotechnology company discovering and developing novel oral small molecule medicines targeting G protein-coupled receptors (GPCRs). Its proprietary Native Complex Platform® is designed to unlock previously difficult-to-drug GPCR targets. The company is advancing programs in endocrinology, immunology and inflammation, and metabolic diseases.
- Founded
- 2019
- Company size
- 51-200
- Headquarters
- South San Francisco, California, US
- Funding
- Series B
Hiring activity
- Open roles
- 4
- Posted in the last 30 days
- 4
Updated 8h ago
Latest openings
4 open roles at Septerna. Members see each one.